These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 26453388

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Replacing a dopamine agonist by the COMT-inhibitor tolcapone as an adjunct to L-dopa in the treatment of Parkinson's disease: a randomized, multicenter, open-label, parallel-group study.
    Ries V, Selzer R, Eichhorn T, Oertel WH, Eggert K, German Tolcapone Study Group.
    Clin Neuropharmacol; 2010 May; 33(3):142-50. PubMed ID: 20502133
    [Abstract] [Full Text] [Related]

  • 23. Off-period screaming accompanying motor fluctuations in Parkinson's disease.
    Steiger MJ, Quinn NP, Toone B, Marsden CD.
    Mov Disord; 1991 May; 6(1):89-90. PubMed ID: 2005932
    [No Abstract] [Full Text] [Related]

  • 24. Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls.
    Ahlskog JE.
    Mayo Clin Proc; 2014 Jul; 89(7):997-1003. PubMed ID: 24996235
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lees' syndrome: a case series.
    Becker N, Munhoz RP, Teive HA.
    Arq Neuropsiquiatr; 2011 Oct; 69(5):756-9. PubMed ID: 22042176
    [Abstract] [Full Text] [Related]

  • 28. Motor fluctuations and levodopa-induced dyskinesias in dopa-responsive dystonia.
    Bendi VS, Shou J, Joy S, Torres-Russotto D.
    Parkinsonism Relat Disord; 2018 May; 50():126-127. PubMed ID: 29467094
    [No Abstract] [Full Text] [Related]

  • 29. Parkinson's disease patients cannot get their dopamine replacement: the 8-Sinemet limit.
    Okun MS.
    Mov Disord; 2012 Mar; 27(3):461-2. PubMed ID: 22162080
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dopamine dysregulation syndrome induced by proxy.
    Reis Carneiro D, Sousa M, Morgadinho A, Januário C.
    BMJ Case Rep; 2019 May 16; 12(5):. PubMed ID: 31101748
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dyskinesias during levodopa-carbidopa intestinal gel (LCIG) infusion: Management inclinical practice.
    Melgari JM, Salomone G, di Biase L, Marano M, Scrascia F, Di Lazzaro V.
    Parkinsonism Relat Disord; 2015 Mar 16; 21(3):327-8. PubMed ID: 25595317
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Absorption of orally disintegrating carbidopa-levodopa requires intact small bowel function.
    Iyer SS, Morgan JC, Sethi KD.
    Neurology; 2005 Nov 08; 65(9):1507. PubMed ID: 16275853
    [No Abstract] [Full Text] [Related]

  • 36. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.
    Klostermann F, Jugel C, Bömelburg M, Marzinzik F, Ebersbach G, Müller T.
    Mov Disord; 2012 Nov 08; 27(13):1704-5. PubMed ID: 23192929
    [No Abstract] [Full Text] [Related]

  • 37. High-dose pergolide monotherapy in the treatment of severe levodopa-induced dyskinesias.
    Facca A, Sanchez-Ramos J.
    Mov Disord; 1996 May 08; 11(3):327-9. PubMed ID: 8723153
    [No Abstract] [Full Text] [Related]

  • 38. Sinemet CR for Parkinson's disease.
    Med Lett Drugs Ther; 1991 Oct 04; 33(854):92-3. PubMed ID: 1895993
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.